Related Experiment Videos
[A combination therapy for hypopharyngeal cancer]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 1984
Summary
This study explores a combined treatment for hypopharyngeal cancer, integrating induction chemotherapy, radical surgery with esophageal reconstruction, and postoperative chemoradiotherapy. This multimodal approach aims to improve pathological outcomes compared to previous methods.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Context:
- Hypopharyngeal cancer treatment has evolved significantly.
- Historically, preoperative chemoradiotherapy was used, but with variable pathological success.
- A shift towards multimodal therapy integrating induction chemotherapy, radical surgery, and postoperative chemo-radiotherapy has occurred.
Purpose:
- To evaluate a combined treatment protocol for hypopharyngeal cancer.
- To assess the efficacy of induction chemotherapy, radical surgery with primary reconstruction, and postoperative chemo-radiotherapy.
- To compare outcomes with previous treatment strategies.
Summary:
- The current protocol involves induction chemotherapy (sequential FT-207, ADR, MMC, Pepleomycin, MMC - FAM-PM).
- Radical surgery includes total laryngopharyngectomy with bilateral neck dissection and pectoralis major myocutaneous flap reconstruction.
- This approach facilitates earlier postoperative chemo-radiotherapy.
Impact:
- The multimodal strategy aims for improved pathohistological outcomes in hypopharyngeal cancer.
- Pectoralis major myocutaneous flap reconstruction enables timely adjuvant therapy.
- This protocol represents an advancement in managing advanced hypopharyngeal cancer.